However, if monocytosis, eosinophilia, splenomegaly, elevated LDH, high KIT D816V variant allele frequency, and/or additional somatic mutations in genes associated with myeloid malignancies are identified, it should prompt careful evaluation to exclude SM-AHN. This evidence concerns the gene KIT and myeloid neoplasm.